These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7121387)

  • 41. Gentamicin and tobramycin. Clinical pharmacokinetics and nephrotoxicity. Aspects on assay techniques.
    Kahlmeter G
    Scand J Infect Dis Suppl; 1979; (18):1-40. PubMed ID: 111346
    [No Abstract]   [Full Text] [Related]  

  • 42. [Side effects of aminoglycosides: nephrotoxicity (author's transl)].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Infection; 1976; 4(4):231-8. PubMed ID: 65328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gentamicin and tobramycin in patients with various infections--nephrotoxicity.
    Kahlmeter G; Hallberg T; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():47-52. PubMed ID: 659349
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparison between the nephrotoxic profile of gentamicin and gentamicin nanoparticles in mice.
    Jamshidzadeh A; Heidari R; Mohammadi-Samani S; Azarpira N; Najbi A; Jahani P; Abdoli N
    J Biochem Mol Toxicol; 2015 Feb; 29(2):57-62. PubMed ID: 25293820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE; Bloxham DD; Thompson WL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study.
    Fong IW; Fenton RS; Bird R
    J Antimicrob Chemother; 1981 Jan; 7(1):81-8. PubMed ID: 7204294
    [No Abstract]   [Full Text] [Related]  

  • 47. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
    Moore RD; Smith CR; Lipsky JJ; Mellits ED; Lietman PS
    Ann Intern Med; 1984 Mar; 100(3):352-7. PubMed ID: 6364908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carvedilol exacerbate gentamicin-induced kidney mitochondrial alterations in adult rat.
    Félix L; Oliveira MM; Videira R; Maciel E; Alves ND; Nunes FM; Alves A; Almeida JM; Domingues MR; Peixoto FP
    Exp Toxicol Pathol; 2017 Feb; 69(2):83-92. PubMed ID: 27899231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary protein level alters gentamicin-induced nephrotoxicity in rats.
    Zeeni N; Selmaoui B; Beauchamp D; Labrecque G; Thibault L
    Physiol Behav; 2007 Apr; 90(5):760-70. PubMed ID: 17336348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Nephrotoxicity of gentamycin and tobramycin in dogs: comparison following continuous perfusion or once daily intravenous injection].
    Thompson WL
    Nouv Presse Med; 1978 Nov; 7(42):3830-2. PubMed ID: 714686
    [No Abstract]   [Full Text] [Related]  

  • 52. [Individual activity of renal enzymes in the susceptibility of hydronephrotic rabbits to aminoglycoside (gentamicin) nephrotoxicity].
    Bushma KM; Bushma MI
    Eksp Klin Farmakol; 2009; 72(2):55-9. PubMed ID: 19441732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
    Smith CR; Lipsky JJ; Lietman PS
    Antimicrob Agents Chemother; 1979 Jun; 15(6):780-2. PubMed ID: 475363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
    Lerner SA; Schmitt BA; Seligsohn R; Matz GJ
    Am J Med; 1986 Jun; 80(6B):98-104. PubMed ID: 3524221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes.
    Li SC; Ioannides-Demos LL; Spicer WJ; Berbatis C; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1989 Aug; 151(4):224-32. PubMed ID: 2761465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ototoxicity caused by topical administration of gentamicin versus tobramycin in rabbits.
    Oghan F; Apuhan T; Yılmaz F
    Int J Pediatr Otorhinolaryngol; 2011 Jul; 75(7):915-8. PubMed ID: 21592592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
    Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
    J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative nephrotoxicity of dibekacin and gentamicin in rats.
    Elliott WC; Parker RA; Houghton DC; Gilbert DN; Bennett WM
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):419-32. PubMed ID: 7330450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of manganese chloride on gentamicin-induced nephrotoxicity in rats.
    Ateşşahin A; Karahan I; Yilmaz S; Ceribaşi AO; Princci I
    Pharmacol Res; 2003 Dec; 48(6):637-42. PubMed ID: 14527830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of dimethyl sulfoxide on gentamicin-induced nephrotoxicity in rats.
    Ali BH; Mousa HM
    Hum Exp Toxicol; 2001 Apr; 20(4):199-203. PubMed ID: 11393273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.